Financhill
Back

Valneva SE 10K Form

Sell
30

VALN
Valneva SE

Last Price:
3.91
Seasonality Move:
-29.37%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive VALN News And Ratings

See the #1 stock for the next 7 days that we like better than VALN

VALN Financial Statistics

Sales & Book Value

Annual Sales: $166.41M
Cash Flow: $-30.64M
Price / Cash Flow: 0
Annual Sales: $3.00
Price / Book: 1.31

Profitability

EPS (TTM): -0.12480
Net Income (TTM): $-7.65M
Gross Margin: $57.2M
Return on Equity: -4.1%
Return on Assets: -1.43%

Valneva SE Earnings Forecast

Key Valneva SE Financial Ratios

  • The Gross Profit Margin over the past 19 years for VALN is 34.37%.
  • The Selling, General & Administrative Expenses for VALN have been equal to 62.81% of Gross Profit Margin.
  • The Research & Development expenses have been 38.97% of Revenue.
  • The Interest Expense is -23.00% of Operating Income.
  • The Net Earning history of VALN is -65.99% of Total Revenues.
  • Per Share Earnings over the last 19 years have been positive in 9 years.

Valneva SE Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: VALN
Website: valneva.com

Debt

Debt-to-Equity Ratio: 0.79
Current Ratio: 2.78
Quick Ratio: 1.71

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

VALN Technical Analysis vs Fundamental Analysis

Sell
30
Valneva SE (VALN) is a Sell

Is Valneva SE a Buy or a Sell?

  • Valneva SE stock is rated a Sell
    The current Valneva SE [VALN] share price is $3.93. The Score for VALN is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.